FOLH1 and prostate cancer: Liu et al.35 conducted a study on a group of newly diagnosed prostate cancer, and their results also showed statistically significant differences in the SUVmax, iTL-PSMA, and iPSMA-TV between the high-risk group and the low-to-medium-risk group.